
Ocular Motor Neurons
Project ALS funds a four-lab consortium working to understand why the motor neurons controlling the eye movement—ocular motor neurons, or OMNs—remain functional in ALS, while
Project ALS funds a four-lab consortium working to understand why the motor neurons controlling the eye movement—ocular motor neurons, or OMNs—remain functional in ALS, while
Project ALS is pleased to share that the FDA has approved the drug edaravone – the first approved ALS treatment in over 20 years. Edaravone,
Results of four recently published Project ALS studies shed new light on how ALS happens, and strategies for slowing the disease. Project ALS teams led
NEW MAILING ADDRESS
2585 Broadway, Suite 202
New York, NY 10025
Phone: (212) 420-7382
Email: [email protected]
Copyright Project ALS 2025 | Built with by Edward Kado